LCTX
Lineage Cell Therapeutics Inc
0.9146$
-7.6%
vs. previous close
Closing price · As of: Nov 13, 2026
Filings
Filings
Listed US companies must report material events to the Securities and Exchange Commission. This page lists the filings of Lineage Cell Therapeutics Inc (LCTX) with date, type and a link to the original document.
| Date | Type | Filing | Original |
|---|---|---|---|
| 11/12/2026 | Current report (8-K) | Lineage Cell Therapeutics, Inc. (LCTX): Entry into a Material Definitive Agreement; Completion of Acquisition or Disposition of Assets; Results of Operations and Financial Condition; Unregistered Sales of Equity Securities; Regulation FD Disclosure; Financial Statements and Exhibits | View report ↗ |
Showing the 100 most recent filings of the selected type.
Data as of: November 13, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · Filings: SEC EDGAR
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.